Home

News & Blog - drug resistance
Weekly digest: ResistanceMap makes national news, Global Fund cuts down AMFm, and whole genome sequencing stops a MRSA outbreak
16 Nov 2012
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Alison Buki
Tags: ACTs, AMFm, animal use, antibiotic use, antibiotics, cost, costs, developing, disease, disease ecology, disease mapping, drug development, drug resistance, Gram negative, gram negs, HAIs, health, health economics, legal, malaria ecology, malaria mapping, malaria vaccine, MRSA, new antibiotics, new drugs, resistance, resistance ecology, resistance policy, ResistanceMap, TB, trends, vaccine
CDDEP in the news: ResistanceMap and joint statement on preserving antibiotic effectiveness make national news coverage
16 Nov 2012
It’s been a momentous week for both CDDEP and Extending the Cure. On Tuesday, in conjunction with the Centers for Disease Control and Prevention and 25 other national health organizations, we issued a joint consensus statement on the need to preserve antibiotic effectiveness and combat resistance.
Read more »
0 Comments
Posted by Alison Buki
Tags: animal use, antibiotic use, antibiotics, cost, disease, disease ecology, disease mapping, drug development, drug resistance, Gram negative, gram negs, HAIs, health, MRSA, new antibiotics, new drugs, policy, prescribing, resistance, resistance ecology, resistance policy, ResistanceMap
Weekly digest: AMFm decision approaches, Get Smart Week, and health organizations unite to preserve antibiotic effectiveness
9 Nov 2012
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Alison Buki
Tags: AMFm, antibiotic use, antibiotics, community, developing, disease, drug resistance, ecology, Gram negative, gram negs, HAIs, health, India, malaria ecology, malaria mapping, MRSA, resistance, resistance ecology
Weekly digest: AMFm in The Lancet, CDDEP at IDWeek, and new treatments for C. Diff and MRSA
2 Nov 2012
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Alison Buki
Tags: ACTs, AMFm, antibiotic use, antibiotics, climate change, developing, disease, disease ecology, disease mapping, drug development, drug resistance, ecology, HAIs, health, health economics, malaria ecology, malaria mapping, MFTs, MRSA, new antibiotics, new drugs, prescribing, resistance
The Affordable Medicines Facility-malaria Reviewed in The Lancet
1 Nov 2012
This week, The Lancet has published two important articles on the Affordable Medicines Facility-malaria (AMFm), an innovative financing mechanism designed to expand access to the most effective treatment for malaria, artemisinin-based combination therapies (ACTs), through high-level subsidies.
Read more »
0 Comments
Posted by admin
Tags: AMFm, developing, disease, disease ecology, disease mapping, drug resistance, elimination, health economics, malaria ecology, malaria mapping, malaria vaccine, MFTs, multiple first-line therapies, resistance, transmission, trends